Results 241 to 250 of about 296,469 (371)

Supporting long‐term engagement in HIV clinical care: Learning from the COVID‐19 pandemic

HIV Medicine, EarlyView.
Abstract Objectives SHIELD is a London‐based study of engagement in HIV clinical care during and after the COVID‐19 pandemic. We document the characteristics of service users who either re‐engaged or disengaged with HIV care, together with reflections of HIV clinical service‐providers to inform recommendations that address care retention for the long ...
R. Dhairyawan, Sara Paparini, M. Smuk, S. Sidat, R. Mbewe, Silvia Petretti, V. Martin, S. Dakshina, H. Alexander, T. D. Appleby, K. Childs, M. Bracchi, B. Dragovic, G. Haidari, N. Mackie, I. Reeves, A. Umaipalan, L. J. Waters, J. Anderson, C. M. Orkin   +19 more
wiley   +1 more source

Changes in liver stiffness measurements following hepatitis C sustained virologic response among Alaska Native adults treated with sofosbuvir-based direct acting anti-viral therapy. [PDF]

Int J Circumpolar Health
Johnston JM, Townshend-Bulson L, McMahon B, Bruden D, Homan C, Desai K, Rhodes W, Barbour Y.   +7 more
europepmc   +1 more source

Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir Achieves Sustained Virologic Response. [PDF]

Fed Pract, 2021
Rife KM, Lea EJ, Hirsch AA, Falck-Ytter Y.   +3 more
europepmc   +1 more source

Ongoing Alcohol Consumptions Counteracts the Benefits of Sustained Virological Response in Patients with Well Compensated Hepatitis C Cirrhosis: an Observational Study

, 2016
Rubén Hernáez, Hashem B. El‐Serag
openalex   +1 more source

Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE‐2 study

HIV Medicine, EarlyView.
Abstract Objectives This study assessed real‐world effectiveness and safety of switching to dual therapy regimens consisting of an integrase inhibitor (INSTI), and reverse transcriptase inhibitor (RTI), among suppressed people living with HIV in Europe.
Cristina Mussini, Cassidy Henegar, Lambert Assoumou, Stephane de Wit, Margaret Johnson, Eugenia Quiros‐Roldan, Chris Kenyon, Colin Deschanvres, David Zucman, Frank Post, Roya Movahedi, Laura Comi, Julie Fox, Geoffrey Liegeon, Charlotte Martin, Jonathan Edwards, Giorgio Tiecco, Marc Delforge, Leigh Ragone, Bryn Jones, Jean van Wyk, Michael Aboud, Carl Fletcher, Anton Pozniak, Vani Vannappagari   +24 more
wiley   +1 more source

Changes in Health-related Quality of Life for Hepatitis C Virus-Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response. [PDF]

Clin Infect Dis, 2022
Gormley MA, Akiyama MJ, Rennert L, Howard KA, Norton BL, Pericot-Valverde I, Muench S, Heo M, Litwin AH.   +8 more
europepmc   +1 more source

Persistence of hepatitis C virus in peripheral blood mononuclear cells of patients who achieved sustained virological response following treatment with direct-acting antivirals is associated with a distinct pre-existing immune exhaustion status [PDF]

Sylwia Osuch, Marie-Pierre Kazek, Paulina Emmel, Hanna Berak, Marek Radkowski, Kamila Caraballo Cortés   +5 more
openalex   +1 more source

Immune non‐response despite effective antiretroviral therapy in people living with HIV: A review of potential mechanisms, biomarkers and therapeutic approaches

HIV Medicine, EarlyView.
Abstract Introduction A proportion of people living with HIV (PLWH) fail to restore their CD4 count or their CD4/CD8 ratio despite effective antiretroviral therapy (ART). PLWH with immune non‐response (INR) are at a higher risk of both AIDS and non‐AIDS events. The underlying mechanisms of INR remain unclear.
Charlotte Silvestre, Antoine Gross, Alain Makinson   +2 more
wiley   +1 more source

Hepatocellular Carcinoma Developing in a Patient 29 Years After Achieving Sustained Virologic Response for Hepatitis C With Interferon Therapy: A Case Report. [PDF]

Cureus
Maezawa Y, Kodama Y, Ariga H, Kashimura J, Irie T.   +4 more
europepmc   +1 more source

Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension. [PDF]

Egypt Liver J, 2022
Faheem HA, Abdulmeged NA, Hussein HA, Elmoursi AA, Elnaggar HTMY, Ghait RS.   +5 more
europepmc   +1 more source